Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.
Patent CN110156658A reveals efficient chiral phosphoric acid catalysis for triarylmethane derivatives ensuring high purity and scalable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with simplified supply chain and significant cost efficiency for global pharmaceutical partners.
Novel synthetic route for 5-hydroxy-1-indenones offering high selectivity and scalable production for pharmaceutical intermediates supply chain optimization.
Patent CN112159312B reveals a mild one-pot synthesis for triarylmethanes. This method offers high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Novel chiral phosphoric acid catalysis for indoline pyrroles ensures high ee and mild conditions. We are a reliable supplier for pharmaceutical intermediates offering significant cost reduction and scalable production capabilities for global partners.
Novel indolocyclopentanes synthesis via chiral phosphoric acid. High yield, mild conditions. Reliable pharmaceutical intermediates supplier for anticancer drug development.
Novel chiral phosphoric acid catalyzed synthesis offers high enantioselectivity and yield for antitumor drug intermediates, ensuring supply chain stability.
Patent CN112079808A reveals a room-temperature route to benzopyrans using binaphthol phosphate. Offers high yield and scalability for API intermediates.
Patent CN110156658A reveals a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and substantial cost reduction in pharma manufacturing supply chains.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel chiral phosphoric acid catalysis enables high-yield, high-ee synthesis of anticancer intermediates, ensuring cost-effective and reliable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high-yield synthesis. Offers cost reduction and supply reliability for antitumor drug intermediates.
Novel synthesis method for axial chiral vinyl indolo compounds. High yield, mild conditions, suitable for pharmaceutical intermediates mass production and supply.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN110452150A reveals high-purity axial chiral indole-naphthalene synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN109384794A reveals protic acid catalyzed route. High yield, green chemistry. Reliable supplier for scale-up.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.